128 related articles for article (PubMed ID: 21223684)
1. [Effect of sorafenib on lymphangiogenesis in subcutaneously transplanted human cholangiocarcinoma in nude mice].
Huang FK; Shi Z
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):808-12. PubMed ID: 21223684
[TBL] [Abstract][Full Text] [Related]
2. [Intervention of rukangyin on the lymphangiogenesis in breast cancer metastasis nude spontaneous mouse model].
Li XQ; Dang XG
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Dec; 31(12):1657-61. PubMed ID: 22384554
[TBL] [Abstract][Full Text] [Related]
3. Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells.
Sugiyama H; Onuki K; Ishige K; Baba N; Ueda T; Matsuda S; Takeuchi K; Onodera M; Nakanuma Y; Yamato M; Yamamoto M; Hyodo I; Shoda J
J Gastroenterol; 2011 Jun; 46(6):779-89. PubMed ID: 21331764
[TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effect of nimesulide and oxaliplatin on tumor growth and lymphatic metastasis of transplanted human lung cancer in nude mice].
Lang Z; Chen G; Wang DC
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):739-44. PubMed ID: 23291066
[TBL] [Abstract][Full Text] [Related]
5. New model of in-situ xenograft lymphangiogenesis by a human colonic adenocarcinoma cell line in nude mice.
Sun JJ; Jing W; Ni YY; Yuan XJ; Zhou HH; Fan YZ
Asian Pac J Cancer Prev; 2012; 13(6):2823-8. PubMed ID: 22938466
[TBL] [Abstract][Full Text] [Related]
6. Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression.
Fava G; Demorrow S; Gaudio E; Franchitto A; Onori P; Carpino G; Glaser S; Francis H; Coufal M; Marucci L; Alvaro D; Marzioni M; Horst T; Mancinelli R; Benedetti A; Alpini G
Liver Int; 2009 Aug; 29(7):1031-42. PubMed ID: 19291182
[TBL] [Abstract][Full Text] [Related]
7. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
[TBL] [Abstract][Full Text] [Related]
8. Effects of rosiglitazone on the growth and lymphangiogenesis of human gastric cancer transplanted in nude mice.
Chen FZ; Mo XM; Wang QP; Li J; Zhang L
Oncol Rep; 2013 Dec; 30(6):2705-12. PubMed ID: 24002492
[TBL] [Abstract][Full Text] [Related]
9. [A study on the effects of indomethacin and oxaliplatin on lymphangiogenesis in a nude mice model of transplantation with A549 human lung cancer].
Zhang MZ; Chen G
Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):107-12. PubMed ID: 22455966
[TBL] [Abstract][Full Text] [Related]
10. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma.
Cadamuro M; Brivio S; Mertens J; Vismara M; Moncsek A; Milani C; Fingas C; Cristina Malerba M; Nardo G; Dall'Olmo L; Milani E; Mariotti V; Stecca T; Massani M; Spirli C; Fiorotto R; Indraccolo S; Strazzabosco M; Fabris L
J Hepatol; 2019 Apr; 70(4):700-709. PubMed ID: 30553841
[TBL] [Abstract][Full Text] [Related]
12. [Effect of xiaotan sanjie recipe on expressions of VEGF-C and VEGFR-3 in nude mice with transplanted human gastric adenocarcinoma cell MKN-45].
Pang B; Wei PK; Li YJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Feb; 31(2):204-8. PubMed ID: 21425575
[TBL] [Abstract][Full Text] [Related]
13. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
[TBL] [Abstract][Full Text] [Related]
14. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
[TBL] [Abstract][Full Text] [Related]
15. [Suppression of the growth of subcutaneous transplanted human liver cancer and lung metastasis in nude mice treated by sorafenib combined with fluorouracil].
Shen HJ; Wang YH; Xu J
Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):98-102. PubMed ID: 23714662
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
17. Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C/VEGFR-3 dependent PI3K/AKT pathway.
Huang B; Lu Y; Gui M; Guan J; Lin M; Zhao J; Mao Q; Lin J
Biomed Pharmacother; 2021 May; 137():111331. PubMed ID: 33578235
[TBL] [Abstract][Full Text] [Related]
18. Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling.
Komuro A; Yashiro M; Iwata C; Morishita Y; Johansson E; Matsumoto Y; Watanabe A; Aburatani H; Miyoshi H; Kiyono K; Shirai YT; Suzuki HI; Hirakawa K; Kano MR; Miyazono K
J Natl Cancer Inst; 2009 Apr; 101(8):592-604. PubMed ID: 19351925
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effect of endostar on lymphangiogenesis in non-small cell lung cancer and its effect on circulating tumor cells].
Shang L; Zhao J; Wang W; Xiao W; Li J; Li X; Song W; Liu J; Wen F; Yue C
Zhongguo Fei Ai Za Zhi; 2014 Oct; 17(10):722-9. PubMed ID: 25342038
[TBL] [Abstract][Full Text] [Related]
20. A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities.
Xu Y; Lu W; Yang P; Peng W; Wang C; Li M; Li Y; Li G; Meng N; Lin H; Kan L; Wang S; Yang S; Yu L; Zhao Y
BMC Cancer; 2015 Jul; 15():525. PubMed ID: 26187637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]